Life Technologies Corporation
5791 Van Allen Way, Carlsbad, CA, 92008, United States
Overview
Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments. Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Biotechnology
- Genetics
- Health Care
- Medical
Investment portfolio
- SG Biofuels
Participated · Series B · Jan 2012
SGB is a San Diego-based agricultural biotechnology and seed company that develops Jatropha hybrids to produce sustainable plant oil, protein and biomass. Its latest generation of Jatropha hybrids has reduced time to maturity from five years to one to two years. The company intends to use the funds to drive commercial partnerships and project deployments in Central America, India and Southeast Asia. It also plans to further advance genetic improvement and agronomic best practices to maximize the crop's potential. In conjunction with the financing, Arama Kukutai joined the board as executive chairman and Miguel Motta as president and chief operating officer; Kirk Haney stepped down as CEO but remains a director. SG Biofuels is a San Diego-based bioenergy crop company developing elite hybrid seeds of Jatropha as a low-cost feedstock for biodiesel, bio jet fuel and specialty chemicals. Jatropha is a subtropical, non-edible energy crop that can be grown on marginal lands considered undesirable for food crops. SG Biofuels uses molecular breeding and biotechnology to improve yields and reduce input costs and has developed proprietary hybrid seed production technology enabling large-scale deployments of higher-yielding, uniform planting material adapted to different growing conditions. The company has signed agreements with Bharat Renewable Energy Limited (BREL) and JETBIO to deploy Jatropha in Brazil for production of bio jet fuel. SG Biofuels plans to use new capital to expand research and development, advance commercialization and scale global operations, and the company is hiring. The company is led by President & Chief Executive Officer Kirk Haney. SG Biofuels is a San Diego-based company that catalogs, develops and produces seeds for jatropha, a drought-resistant plant used to make biodiesel, jet fuel, soaps, organic fertilizers, medicines and pesticides. The company operates a crop improvement platform that it says has doubled jatropha yield and reduced input costs for growers. Two United Nations agencies reported that jatropha seeds can be processed into lower-polluting biodiesel and that seed cake can be used as fertilizer and animal feed after detoxification. Jatropha is regarded by some environmentalists as a favorable non-food biofuel source, but the crop has generated controversy: reporting cited in the article notes jatropha plantations displaced food crops in the Philippines and that forestry groups in India drained rice fields and reclassified public land to cultivate jatropha. SG Biofuels recently raised financing that is part of its current financial position and development efforts.
Team
No current team members are available.